KWESST Provides Corporate Update to Investors

KWESST Provides Corporate Update to Investors

Company releases Fiscal Q3 Financial Results

KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) ("KWESST" or "the Company"), a publicly-traded company listed on the TSX Venture Exchange (symbol: KWE) and the OTCQB© Markets (symbol: KWEMF) today provided a corporate update to investors in conjunction with the filing of its Q3 Fiscal 2021 financial results.

"We continue to make quiet but steady progress against our plan on all fronts," said Jeff MacLeod, KWESST Founder, President and CEO, who reported as follows on the Company's various product areas.

Non-lethal Low Energy Cartridge (LEC) system

He added: "Regarding our non-lethal Low Energy Cartridge (LEC) system we are currently producing units which will be used as demonstration samples following the successful investor demonstration in British Columbia on July 9th of this year. The first, high-priority versions are for personal protection and law enforcement, to be available later this year and followed by an official commercial launch at the 2022 SHOT Show in Las Vegas on January 18-23. We are working with end-users and influencers in the industry who have provided helpful and very encouraging initial feedback. We are also pleased at the support of influencers like Brandon Tatum, who expressed enthusiasm for the LEC in an interview with KWESST Executive Chairman David Luxton, on August 6th." https://www.youtube.com/watch?v=938LuSbl9yo&t=755s

Android Team Awareness Kit (ATAK) integration services

The Company reported that its pipeline of sales opportunities for ATAK integration services stands at more than $40M and growing. "These opportunities are with major end-users in NATO countries and with Tier 1 and Tier 2 global defense contractors," said MacLeod. "We expect these to result in initial contracts and teaming agreements starting in Q1 of Fiscal 2022, with more to follow through 2022 and extending to 2023, 2024 and beyond."

Innovation Solutions Canada ("ISC")

As announced on August 5th, KWESST received notification from ISC that it has qualified for up to $1.5M in non-dilutive funding to advance its counter-UAS technology, its PhantomTM electronic decoy and its Tactical Awareness and Situational Control System (TASCS) Indirect Fire Module (IFM) system currently under contract with a key U.S. military customer.

"The last phase of our current TASCS IFM contract for this U.S. military customer is scheduled for completion this October," said MacLeod, who added, "We are currently in discussions with this customer regarding next phases of procurement. We are also submitting proposals to other NATO customers with similar requirements."

PhantomTM electronic decoy

The Company remarked that it is seeing accelerated interest in its PhantomTM electronic decoy following a successful demonstration to U.S. Special Operations Command (USSOCOM) in June of this year and is currently producing upgraded units to be used as demonstration samples in response to other U.S. Department of Defense ("DoD") requests for trials and potential initial procurement before the end of calendar 2021. As well, the Company continues to develop ever-stronger IP around this technology and recently received yet another U.S. patent, this one covering methods of employment in addition to previous patents covering the technology itself.

GreyGhost ® counter-drone

KWESST is also working with DoD and another NATO country on upgraded capability for the GreyGhost ® counter-drone system to deal with next-generation drone threats and has commenced engagement with major defense contractors on potential partnerships.

Partnerships

"It is a key part of our go-to-market plan to partner with global defense prime and major sub-contractors," said MacLeod, "We announced a handful of such partnerships early on. The past few months have been especially active in progressing discussions with several others on all fronts, which is expected to result in announcements in the coming weeks and months."

Attendance at trade shows

The international defense market has seen relaxed COVID-19 restrictions with the re-opening of major trade shows and events. "We attended IDEX, the premier Middle East event in Abu Dhabi this past February and announced the appointment of Bin Hilal Enterprises, LLC as our representative in the key Middle East market of the United Arab Emirates," said MacLeod. "We will also be exhibiting at the reopening of DSEI, the major European defense show in London, UK, this September, as well as the Modern-Day Marine show, also in September, and AUSA, the major annual U.S. Army event in Washington DC in October."

Other

On August 24, 2021, the Company's Board of Directors granted 546,000 incentive stock options (the "Options") to officers, employees, and a consultant. The exercise price for the Options will be the closing price of the Company's shares on the TSXV on August 25, 2021 and will vest semi-annually from the date of the grant and will expire on August 24, 2026. Following the end of the quarter, the Company was notified by the lead agent of its April 2021 private placement that a subscription for 40,000 units had been omitted from the closing. Following TSX-V approval, KWESST accepted this subscription.

About KWESST

KWESST develops and commercializes breakthrough next-generation tactical systems that meet the requirements of security forces and personal defense for overmatch capability against adversaries. The company's current portfolio of unique proprietary offerings include its unique non-lethal Low Energy Cartridge (LEC) system with application across all segments of the non-lethal market, including law enforcement and personal defence. KWESST is also involved in the digitization of tactical forces for shared situational awareness and targeting with its signature TASCSTM (Tactical Awareness and Situational Control System) for real-time awareness and targeting information from any source (including drones) streamed directly to users' smart devices and weapons. Other KWESST products include counter-measures against threats such as drones, lasers and electronic detection. These include the autonomous GreyGhostTM soldier-portable micro drone missile system that defends against small hostile drones including swarms using high-speed kinetic impact; a Ground Laser Defence system to counter the emerging threat of weaponized lasers against personnel and the PhantomTMelectronic battlefield decoy system to mask the electromagnetic signature of friendly forces with decoy signatures at false locations to deceive and confuse adversaries. These systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems. The Company is headquartered in Ottawa, Canada, with representative offices in Washington, DC, London, UK and Abu Dhabi, UAE. KWESST trades on the TSX Venture Exchange under the symbol KWE and on the U.S. OTCQB under the symbol KWEMF.

Contact: Jason Frame, Investor Relations: frame@kwesst.com

For more information, please visit https://kwesst.com/

Cautionary Note Regarding Forward-Looking Statements

This news release includes certain "forward-looking statements" under applicable Canadian securities legislation for the purpose of providing information about management's current expectations and plans relating to the future. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. KWESST disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/94372

News Provided by Newsfile via QuoteMedia

The Conversation (0)
Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targeted Hyperthermia Therapy ("THT") which uses the Company's patented, biocompatible gold nanorods ("GNRs") to treat certain solid cancer tumors, shrinking them and acting as an immune stimulator. Building on its success in melanoma and breast cancer studies, the Company's third preclinical efficacy study was conducted in an immunologically 'cold' colorectal cancer model ("CT26"), a model that represents the majority of human colon cancers, which do not typically respond to current standard of care immunotherapies.

In this preliminary study, whereas no mice that were given standard immunotherapy alone showed any response, 100% of mice in the THT treatment group responded to the same immunotherapy with 50% (4 out of 8) of those tumors eliminated within 12 days of treatment, as shown by the green line in Figure 1, below.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is pleased to announce the establishment of its new Advisory Board. The Advisory Board will collaborate with management and the board of directors to enhance the Company's strategic direction, provide expert guidance on its commercial initiatives, offer industry insights, and shape and accelerate innovations.

As the inaugural member of the Advisory Board, Syntheia welcomes Mr. John Kirk, a leader in the travel industry. The travel sector represents a potentially significant growth market for the Company's technology.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is transforming customer service by delivering an innovative solution that uses natural language processing (NLP) to handle inbound telephone calls with virtual assistants. Since its beta launch in June 2023, Syntheia has processed over 750,000 conversations, bringing new levels of efficiency and engagement to businesses in diverse industries.

Companies like Georgetown Hyundai, Palmieri Furniture, Campio Furniture, and Pay N Go have all embraced Syntheia's platform, highlighting its positive impact on sales and customer satisfaction.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Zero Candida Technologies Inc.  Opens the Market

Zero Candida Technologies Inc. Opens the Market

Eli Ben-Haroosh, Co-Founder and Chief Executive Officer, Zero Candida Technologies Inc. (TSXV: ZCT) ("Zero Candida" or the "Company"), joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange, to open the market to celebrate the Company's new listing on the TSX Venture Exchange.

Zero Candida Technologies, Inc. (ZCT), is a medical device company bringing female healthcare into the 21st century. They are transforming the treatment of Vulvo-Vaginal Candidiasis ("VVC"), which affects 75% of women worldwide, often recurrent and increasingly drug-resistant with current treatments failing to address the root cause effectively. Free from chemicals and side effects, their AI-driven tampon-like device enables real-time data collection and transmission to physicians for personalized, at-home treatment. Beyond VVC, ZCT aims to revolutionize gynecology, improving access for underserved populations and advancing hybrid medicine.

Please refer to the Company's website here.

MEDIA CONTACT:
Victoria Gamble
Corporate Development Consultant
victoria@zero-candida.com
416-706-0332

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231280

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
XReality Group

xReality Group Limited Chairman’s Address 2024 Annual General Meeting – 22 November 2024

xReality Group Limited (ASX:XRG) (xReality) is pleased to present xReality Group Limited’s 2024 Annual General Meeting.

Keep reading...Show less
XReality Group

Operator XR – Sales Update November 24

xReality Group Limited (ASX:XRG) (xReality) is pleased to provide the following sales update for Operator XR, a wholly owned subsidiary of xReality Group Ltd. Operator XR provides Military and Law Enforcement agencies around the world with a unique, integrated Mission Planning & Rehearsal System, which is portable, secure, and highly immersive.

Keep reading...Show less

Latest Press Releases

Related News

×